Trials 6 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT03871725 | Jan 2019 → Jan 2020 | atherosclerosis | First Affiliated Hospital of Harbin Medical University | Completed | No outcome recorded |
| Phase 1/24 trials | ||||||
| Phase 1/2 | NCT03382249 | Sep 2023 | atherosclerosis | First Affiliated Hospital of Harbin Medical University | Withdrawn | No outcome recorded |
| Phase 1/2 | NCT03967730 | Jun 2019 → May 2020 | peripheral arterial disease | First Affiliated Hospital of Harbin Medical University | Withdrawn | No outcome recorded |
| Phase 1/2 | NCT03457662 | Mar → Dec 2018 | atherosclerosis, peripheral arterial disease | First Affiliated Hospital of Harbin Medical University | Completed | No outcome recorded |
| Phase 1/2 | NCT03318484 | Nov 2017 → Nov 2019 | atherosclerosis, peripheral arterial disease | First Affiliated Hospital of Harbin Medical University | Withdrawn | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT05386056 | Dec 2022 → Oct 2023 | esophageal squamous cell carcinoma | Peking University | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sinoporphyrin Sodium | “Sonodynamic Therapy (SDT) Sinoporphyrin Sodium (DVDMS) as sonosensitizer, is dissolved in 0.9% sodium solution for following skin test and intravenous injection.” NCT03967730 ↗5“Sinoporphyrin sodium (DVDMS) as sonosensitizer, is dissolved in 0.9% sodium solution for following skin test and intravenous injection.” NCT03318484 ↗ “Sinoporphyrin sodium (DVDMS) as sonosensitizer, is dissolved in 0.9% sodium solution for following skin test and intravenous injection.” NCT03457662 ↗ “Sinoporphyrin sodium (DVDMS) as sonosensitizer, is dissolved in 0.9% sodium solution for following skin test and intravenous injection.” NCT03382249 ↗ “Sinoporphyrin sodium (DVDMS) as sonosensitizer” NCT03871725 ↗ |
| Known as | DVDMS | “Sonodynamic Therapy (SDT) Sinoporphyrin Sodium (DVDMS) as sonosensitizer, is dissolved in 0.9% sodium solution for following skin test and intravenous injection.” NCT03967730 ↗4“Sinoporphyrin sodium (DVDMS) as sonosensitizer, is dissolved in 0.9% sodium solution for following skin test and intravenous injection.” NCT03318484 ↗ “Sinoporphyrin sodium (DVDMS) as sonosensitizer, is dissolved in 0.9% sodium solution for following skin test and intravenous injection.” NCT03457662 ↗ “Sinoporphyrin sodium (DVDMS) as sonosensitizer, is dissolved in 0.9% sodium solution for following skin test and intravenous injection.” NCT03382249 ↗ “Sinoporphyrin sodium (DVDMS) as sonosensitizer” NCT03871725 ↗ |
| Modality | Other / unclassified | “Sinoporphyrin sodium (DVDMS) as sonosensitizer” NCT03457662 ↗ |
| Route | Intravenous | “0.04 mg/ml DVDMS solution intravenous injection (0.2mg/kg).” NCT03318484 ↗ |